Anavex Life Sciences Corp. (AVXL)
NASDAQ: AVXL · Real-Time Price · USD
2.420
+0.030 (1.26%)
At close: Jul 20, 2026, 4:00 PM EDT
2.365
-0.055 (-2.27%)
After-hours: Jul 20, 2026, 7:55 PM EDT
Anavex Life Sciences Market Cap
Anavex Life Sciences has a market cap or net worth of $224.27 million as of July 20, 2026. Its market cap has decreased by -76.08% in one year.
Market Cap
224.27M
Enterprise Value
92.52M
1-Year Change
-76.08%
Ranking
Category
Stock Price
$2.42
ChartMarket Cap Chart
Since October 28, 2015, Anavex Life Sciences's market cap has decreased from $284.60M to $224.27M, a decrease of -21.20%. That is a compound annual growth rate of -2.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 224.27M | -29.50% |
| Dec 31, 2025 | 318.10M | -65.08% |
| Dec 31, 2024 | 910.90M | 19.20% |
| Dec 29, 2023 | 764.20M | 5.86% |
| Dec 30, 2022 | 721.90M | -45.24% |
| Dec 31, 2021 | 1.32B | 264.55% |
| Dec 31, 2020 | 361.60M | 148.69% |
| Dec 31, 2019 | 145.40M | 100.00% |
| Dec 31, 2018 | 72.70M | -48.95% |
| Dec 29, 2017 | 142.40M | -9.24% |
| Dec 30, 2016 | 156.90M | -18.58% |
| Dec 31, 2015 | 192.70M | -32.29% |
| Oct 28, 2015 | 284.60M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Protara Therapeutics | 230.44M |
| Compugen | 224.17M |
| Nautilus Biotechnology | 221.12M |
| Orchestra BioMed Holdings | 220.36M |
| Invivyd | 218.75M |
| AC Immune | 218.24M |
| Coherus Oncology | 215.95M |
| Karyopharm Therapeutics | 215.52M |